Latest news
Is MannKind (MNKD) Undervalued After Positive INFLO 1 Data For Its IPF Pipeline? - simplywall.stsimplywall.st · Mon, 10 Aug 2026 19:46:03 GMTWhy MannKind (MNKD) Is Up 5.1% After Positive Inhaled Nintedanib Data Despite Q2 Net Loss - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:32:25 GMTMannKind (MNKD) insider Steven Binder plans 39,051-share Rule 144 stock sale - Stock TitanStock Titan · Fri, 07 Aug 2026 20:39:26 GMTMannKind price target lowered to $13 from $14 at Wells Fargo - TipRanksTipRanks · Thu, 06 Aug 2026 14:56:25 GMTMannKind Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 20:08:53 GMTWhy MannKind (MNKD) Is Down 5.3% After Dual Lung And Heart Failure Milestones And What's Next - webull.comwebull.com · Sat, 01 Aug 2026 07:00:00 GMTAnalysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Icon (ICLR) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 14:10:00 GMTVanguard Capital Management (MNKD) discloses 15.45M-share, 5% MannKind position - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT